Briaud Financial Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-937
Closed -$217K 38
2025
Q3
$217K Sell
937
-62
-6% -$12.6K 0.07% 33
2025
Q2
$185K Buy
999
+62
+7% +$11.5K 0.07% 40
2025
Q1
$196K Hold
937
0.08% 33
2024
Q4
$166K Sell
937
-100
-10% -$18.4K 0.07% 36
2024
Q3
$204K Hold
1,037
0.11% 25
2024
Q2
$177K Hold
1,037
0.1% 23
2024
Q1
$189K Buy
+1,037
New +$179K 0.11% 23
2023
Q4
Sell
-1,078
Closed -$160K 11
2023
Q3
$160K Buy
+1,078
New +$158K 0.13% 25
2023
Q1
Sell
-1,634
Closed -$264K 21
2022
Q4
$264K Sell
1,634
-185
-10% -$28.4K 0.21% 17
2022
Q3
$268K Buy
1,819
+185
+11% +$26.5K 0.24% 22
2022
Q2
$250K Hold
1,634
0.16% 21
2022
Q1
$264K Hold
1,634
0.15% 21
2021
Q4
$221K Buy
+1,634
New +$193K 0.12% 24
2021
Q2
Sell
-2,125
Closed -$230K 21
2021
Q1
$230K Buy
2,125
+2,018
+1,886% +$216K 0.17% 20
2020
Q4
$227 Buy
+107
New +$10.3K 0.15% 15
2020
Q3
Sell
-2,125
Closed -$208K 19
2020
Q2
$208K Buy
+2,125
New +$187K 0.16% 18

Other funds holding ABBV

Briaud Financial Planning's ABBV Position: Q4 2025 in Review

Briaud Financial Planning sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 937 shares — an estimated $217K sold.

Briaud Financial Planning first reported a position in ABBV in Q2 2020 and held it in 16 quarters. The position peaked at $268K in Q3 2022. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Briaud Financial Planning reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Briaud Financial Planning sold 937 AbbVie shares in Q4 2025, an estimated $217K.
  • Briaud Financial Planning first reported a position in AbbVie in Q2 2020 and held it in 16 quarters.
  • Briaud Financial Planning's AbbVie position peaked at $268K in Q3 2022.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Briaud Financial Planning's 13F filing for Q4 2025, filed 28 Jan 2026.